Hantz Financial Services’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$140K Buy
1,863
+692
+59% +$44.5K ﹤0.01% 1261
2026
Q1
$66K Sell
1,171
-543
-32% -$35.4K ﹤0.01% 1450
2025
Q4
$137K Buy
1,714
+590
+52% +$39.6K ﹤0.01% 1020
2025
Q3
$55K Buy
1,124
+998
+792% +$61.8K ﹤0.01% 1196
2025
Q2
$9K Buy
126
+102
+425% +$6.75K ﹤0.01% 1546
2025
Q1
$2K Buy
24
+16
+200% +$1.09K ﹤0.01% 1368
2024
Q4
$1K Hold
8
﹤0.01% 1037
2024
Q3
$1K Hold
8
﹤0.01% 1020
2024
Q2
$1K Hold
8
﹤0.01% 1003
2024
Q1
$1K Sell
8
-62
-89% -$4.87K ﹤0.01% 1123
2023
Q4
$6K Buy
70
+61
+678% +$5.27K ﹤0.01% 881
2023
Q3
$1K Hold
9
﹤0.01% 1072
2023
Q2
$1K Hold
9
﹤0.01% 1036
2023
Q1
$1K Hold
9
﹤0.01% 1058
2022
Q4
$1K Hold
9
﹤0.01% 1019
2022
Q3
$1K Sell
9
-2
-18% -$144 ﹤0.01% 1017
2022
Q2
$1K Sell
11
-2
-15% -$118 ﹤0.01% 993
2022
Q1
$1K Hold
13
﹤0.01% 989
2021
Q4
$1K Sell
13
-6
-32% -$366 ﹤0.01% 838
2021
Q3
$1K Hold
19
﹤0.01% 790
2021
Q2
$1K Sell
19
-585
-97% -$41.4K ﹤0.01% 782
2021
Q1
$67K Sell
604
-990
-62% -$123K ﹤0.01% 513
2020
Q4
$189K Sell
1,594
-634
-28% -$68.3K 0.01% 407
2020
Q3
$194K Buy
+2,228
New +$195K 0.01% 379

Other funds holding HAE

Hantz Financial Services's HAE Position: Q2 2026 in Review

Hantz Financial Services increased its Haemonetics (HAE) stake by 59% in Q2 2026, buying an estimated $44.5K and bringing the position to 1,863 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1261.

Hantz Financial Services first reported a position in HAE in Q3 2020 and has held it in 24 quarters since. The position peaked at $194K in Q3 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Hantz Financial Services held 1,863 shares of Haemonetics worth $140K as of Q2 2026.
  • Hantz Financial Services bought 692 Haemonetics shares in Q2 2026, an estimated $44.5K.
  • Haemonetics made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1261 holding.
  • Hantz Financial Services first reported a position in Haemonetics in Q3 2020 and has held it in 24 quarters since.
  • Hantz Financial Services's Haemonetics position peaked at $194K in Q3 2020.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.